cytarabine has been researched along with Lymphoma, T-Cell in 49 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (16.33) | 18.2507 |
| 2000's | 22 (44.90) | 29.6817 |
| 2010's | 17 (34.69) | 24.3611 |
| 2020's | 2 (4.08) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, M; Goto, H; Hasegawa, D; Honda, T; Kumamoto, T; Ogawa, S; Takagi, M; Terao, YM; Yamaoka, M; Yoshida, K | 1 |
| Chen, PY; Chuang, CC; Hsu, PW; Huang, YC; Jung, SM; Lin, TK; Tu, PH; Wei, KC; Yeh, TH | 1 |
| Guo, W; Huang, J; Huang, S; Huang, X; Jin, J; Li, C; Li, X; Ma, Z; Xu, Y; Yan, X; Yu, M; Zhou, Y | 1 |
| Agostoni, V; Couvreur, P; Gref, R; Lampropoulou, M; Lazarou, YG; Maksimenko, A; Rodriguez-Ruiz, V; Salzano, G; Yannakopoulou, K | 1 |
| Al Aoun, SM; AlHalouli, TM; Iqbal, S; Motabi, IH; Zaidi, SZ | 1 |
| Ichimura, Y; Kamata, M; Kamikubo, Y; Kurokawa, M; Mitsui, H; Miyagaki, T; Sato, S; Sonoda, K; Sugaya, M | 1 |
| Chalmers, AW; Gregory, SA; Katz, DA; Miller, IJ | 1 |
| Shustov, A | 1 |
| Czajczynska, A; Gramatzki, M; Günther, A; Humpe, A; Kneba, M; Nickelsen, M; Raff, T; Repp, R; Schrappe, M; Schrauder, A; Schub, N | 1 |
| Kraus, TS; Tan, BT; Twist, CJ | 1 |
| Chen, H; Chen, J; Du, G; Han, Q; Liu, C; Sun, M; Wang, W; Wu, L | 1 |
| Melendez-Rosado, JM; Stancampiano, FF; Zetir, M | 1 |
| Fujisawa, S; Hagihara, M; Ishii, Y; Itabashi, M; Matsumoto, K; Motohashi, K; Numata, A; Yamamoto, W | 1 |
| Anagnostopoulos, I; Kanz, L; Pezzutto, A; Subklewe, M; Weidmann, E; Weisel, KC | 1 |
| Huh, J; Kim, BS; Kim, K; Kim, SJ; Kim, WS; Ko, YH; Suh, C | 1 |
| Chott, A; Friedrich, C; Janka-Schaub, G; Kabisch, H; Schrum, J | 1 |
| Ikegame, K; Imai, Y; Inoue, D; Kimura, T; Kurata, M; Matsushita, A; Mori, M; Nagai, K; Nagai, Y; Ogawa, H; Shimoji, S; Tabata, S; Takahashi, T; Togami, K | 1 |
| Hsiao, PF; Lin, J; Wu, YH | 1 |
| Albiero, E; Bernardi, M; Castegnaro, S; Chieregato, K; Madeo, D; Rodeghiero, F; Visco, C; Zanon, C | 1 |
| Ambrosio, MR; Carmellini, M; Fabbri, A; Ginori, A; Lazzi, S; Onorati, M; Rocca, BJ; Tripodi, S | 1 |
| Berger, F; Cimarelli, S; Formaglio, M; Ghesquières, H; Lachenal, F | 1 |
| Al Awadi, S; Al Shemmari, S; Bajciova, V; Mottl, H; Nemec, J | 1 |
| Hagimoto, T; Kanda, M; Maeda, K; Ohshima, K; Okada, M; Sakamoto, A; Sonoda, T; Suzumiya, J; Tamura, K; Wakamatsu, S | 1 |
| Frankel, MC; Georgala, S; Itakura, H; Junkins-Hopkins, JM; Rook, AH; Schuster, SJ; Shapiro, M; Vittorio, CC; Wasik, MA | 1 |
| Fehlings, T; Grehl, S; Kleuker, S; Pöttgen, C; Rauhut, F; Schmitz, A; Schwechheimer, K; Stüben, G; Stuschke, M; Wacker, HH; Wilhelm, H | 1 |
| Nishimura, J; Ohshima, K; Shiokawa, S; Shiratsuchi, M; Suehiro, Y; Yoshikawa, Y | 1 |
| Hoang-Xuan, K; Levy, V; Soussain, C | 1 |
| Cho, KJ; Cho, SG; Lee, DH | 1 |
| Gou, HF; Hou, M; Li, L; Qiu, M; Yan, X; Zhu, J | 1 |
| Benedetti, F; Cantini, M; Crippa, C; Draisci, M; Pasini, F; Pizzolo, G; Tecchio, C; Todeschini, G | 1 |
| Crump, M; Lin, B; Shepherd, L | 1 |
| Hino, M; Hirose, A; Koh, H; Mugitani, A; Nakajima, Y; Nakamae, H; Nakamae, M; Nakane, T; Nakao, Y; Takeoka, Y; Teshima, H; Yagi, T; Yamamura, R; Yamane, T | 1 |
| Gill, DS; Hawley, CM; Marlton, PV; Norris, D; Tey, SK | 1 |
| Gadner, H; Henze, G; Ludwig, WD; Müller-Weihrich, S; Parwaresch, R; Reiter, A; Riehm, H; Sauter, S; Schrappe, M; Sykora, KW | 1 |
| Allione, A; Bernabei, P; Forni, G; Novelli, F; Rigamonti, L | 1 |
| Amiot, L; Caulet-Maugendre, S; Diebold, J; Drénou, B; Fardel, O; Fauchet, R; Lamy, T; Le Prisé, PY; Sasportes, M | 1 |
| Hizawa, Y; Itoh, J; Kawamura, S; Munakata, A; Nakui, Y; Saitoh, S; Satoh, T; Taka-mi, H; Tamura, Y; Tsushima, K | 1 |
| den Boer, ML; Durian, M; Janka, G; Kaspers, GJ; Pieters, R; Schmiegelow, K; van Wering, ER; Veerman, AJ | 1 |
| Astori, C; Bernasconi, C; Bernasconi, P; Lazzarino, M; Orlandi, E | 1 |
| Cinatl, J; Doerr, HW; Driever, PH; Gröschel, B; Kabickova, H; Kornhuber, B; Kotchetkov, R; Schwabe, D | 1 |
| Sakai, C; Takagi, T; Tamaru, J; Tsujimura, H | 1 |
| Dobie, D; Hastings, M; Mahendra, P; Richardson, G; Tauro, S | 1 |
| Achour, E; Azar, N; Belanger, C; Cassoux, N; Delattre, JY; Gerber, S; Hoang-Xuan, K; Leblond, V; Levy, V; Ribrag, V; Soussain, C; Suzan, F | 1 |
| Aoyama, Y; Hasegawa, T; Hino, M; Inoue, T; Koh, KR; Nakamae, H; Ota, K; Sakamoto, C; Takubo, T; Tatsumi, N; Tsubaki, K; Yamamura, R; Yamane, T | 1 |
| DeAngelis, LM; Gijtenbeek, JM; Rosenblum, MK | 1 |
| Gadner, H; Grenzebach, J; Ludwig, WD; Parwaresch, R; Reiter, A; Riehm, H; Schrappe, M; Zimmermann, M | 1 |
| Heslop, HE; Khan, S; Krance, RA; Kuehnle, I; Rodriguez, V | 1 |
| Ekman, T; Goldkuhl, C; Telhaug, R; Wiklund, T | 1 |
| Kleinschmidt-DeMasters, BK; Yeh, M | 1 |
4 review(s) available for cytarabine and Lymphoma, T-Cell
| Article | Year |
|---|---|
Hepatosplenic T-cell lymphoma: is cure possible?
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Female; Humans; Liver; Lymphoma, T-Cell; Methylprednisolone; Spleen; Stem Cell Transplantation | 2013 |
Renal infarction due to polyarteritis nodosa in a patient with angioimmunoblastic T-cell lymphoma: a case report and a brief review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cytarabine; Diagnostic Errors; Humans; Immunoblastic Lymphadenopathy; Immunohistochemistry; Infarction; Kidney; Kidney Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphoma, T-Cell; Male; Polyarteritis Nodosa; Predictive Value of Tests; Stem Cell Transplantation; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2012 |
Natural killer T-cell lymphoma of the tongue.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Killer Cells, Natural; Lymphoma, T-Cell; Male; Methotrexate; Prednisone; Radiotherapy, Adjuvant; Tongue Diseases; Tongue Neoplasms; Ulcer; Vincristine | 2005 |
Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Transitional Cell; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Immunosuppression Therapy; Kidney Transplantation; Liver Neoplasms; Lymphoma, T-Cell; Methotrexate; Middle Aged; Neoplasms, Second Primary; Postoperative Complications; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Splenic Neoplasms; Urinary Bladder Neoplasms; Vesico-Ureteral Reflux; Vincristine | 2008 |
7 trial(s) available for cytarabine and Lymphoma, T-Cell
| Article | Year |
|---|---|
Alemtuzumab and DHAP (A-DHAP) is effective for relapsed peripheral T-cell lymphoma, unspecified: interim results of a phase II prospective study.
Topics: Adult; Alemtuzumab; Anemia; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leukopenia; Longitudinal Studies; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prospective Studies; Recurrence; Salvage Therapy; Survival Analysis; T-Lymphocytes; Thrombocytopenia; Treatment Outcome; Young Adult | 2009 |
[Clinical randomized comparative trial of ProMACE-CytaBOM regimen and CHOP regimen in treating non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Nausea; Prednisone; Remission Induction; Survival Rate; Thrombocytopenia; Vincristine | 2005 |
A randomized phase III study of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin as salvage chemotherapy followed by posttransplantation rituximab maintenance therapy versus observation for treatment of aggressive
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cytarabine; Deoxycytidine; Dexamethasone; Gemcitabine; Humans; Lymphoma, B-Cell; Lymphoma, T-Cell; Rituximab | 2005 |
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Clinical Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Infant; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Time Factors | 1995 |
Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Eye Neoplasms; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Nervous System Diseases; Salvage Therapy; Thiotepa | 2001 |
Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Austria; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Germany; Humans; Immunophenotyping; Infant; Life Tables; Lymphoma, T-Cell; Male; Mercaptopurine; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Thioguanine; Treatment Outcome; Vincristine | 2001 |
Age-adjusted chemotherapy for primary central-nervous system lymphoma--a pilot study.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Cytarabine; Dexamethasone; Female; Follow-Up Studies; Humans; Injections, Spinal; Leucovorin; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Middle Aged; Pilot Projects; Radiotherapy, Adjuvant; Vincristine | 2002 |
38 other study(ies) available for cytarabine and Lymphoma, T-Cell
| Article | Year |
|---|---|
Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation.
Topics: Child, Preschool; Cord Blood Stem Cell Transplantation; Cyclin-Dependent Kinase Inhibitor p16; Cyclophosphamide; Cytarabine; DNA-Binding Proteins; Etoposide; ETS Translocation Variant 6 Protein; Female; Gene Deletion; Humans; Liver Neoplasms; Lymphoma, T-Cell; PAX5 Transcription Factor; Prognosis; Proto-Oncogene Proteins c-ets; Remission Induction; Repressor Proteins; Splenic Neoplasms; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2022 |
Primary Central Nervous System Lymphomas of the Brain: A Retrospective Analysis in a Single Institution.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Burkitt Lymphoma; Cranial Irradiation; Craniotomy; Cytarabine; Cytoreduction Surgical Procedures; Female; Humans; Injections, Spinal; Kaplan-Meier Estimate; L-Lactate Dehydrogenase; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neurosurgical Procedures; Prognosis; Retrospective Studies; Survival Rate; Young Adult | 2017 |
Chidamide in FLT3-ITD positive acute myeloid leukemia and the synergistic effect in combination with cytarabine.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Differentiation; Cell Line, Tumor; Cytarabine; Drug Synergism; fms-Like Tyrosine Kinase 3; G1 Phase; Histone Deacetylase Inhibitors; Humans; Leukemia, Myeloid, Acute; Lymphoma, T-Cell; Mutation; Resting Phase, Cell Cycle; Signal Transduction | 2017 |
Positively charged cyclodextrins as effective molecular transporters of active phosphorylated forms of gemcitabine into cancer cells.
Topics: Antimetabolites, Antineoplastic; Biological Transport; Breast Neoplasms; Cyclodextrins; Cytarabine; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Lymphoma, T-Cell; Models, Theoretical; Phosphorylation; Tumor Cells, Cultured | 2017 |
Durable remission of a patient with primary cutaneous CD8
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; CD8-Positive T-Lymphocytes; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, T-Cell; Male; Methotrexate; Remission Induction; Skin Neoplasms; Vincristine | 2021 |
A case of CD20-positive peripheral T-cell lymphoma treated with rituximab and multiagent chemotherapy.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, T-Cell; Methylprednisolone; Prednisone; Rituximab; T-Lymphocytes; Vincristine | 2014 |
Successful treatment of hepatosplenic T-cell lymphoma with ESHAP followed by autologous stem cell transplant.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Female; Humans; Liver; Lymphoma, T-Cell; Methylprednisolone; Spleen; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome | 2013 |
Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin's lymphoma.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, T-Cell; Male; Melphalan; Middle Aged; Remission Induction; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous | 2013 |
Angioimmunoblastic T cell lymphoma: an unusual presentation of posttransplant lymphoproliferative disorder in a pediatric patient.
Topics: Alveolitis, Extrinsic Allergic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Cyclophosphamide; Cytarabine; Etoposide; Heart Transplantation; Humans; Hydrocortisone; Immunoblastic Lymphadenopathy; Immunocompromised Host; Immunophenotyping; Immunosuppressive Agents; Kartagener Syndrome; Lymphoma, T-Cell; Methotrexate; Mycophenolic Acid; Oculomotor Nerve Diseases; Postoperative Complications; Prednisone; Remission Induction; T-Lymphocyte Subsets; Tacrolimus; Vincristine | 2014 |
Primary distal femur T-cell lymphoma after allogeneic haematopoietic stem cell transplantation for chronic myeloid leukaemia: a rare case report and literature review.
Topics: Adult; Angiogenesis Inhibitors; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Harringtonines; Hematopoietic Stem Cell Transplantation; Homoharringtonine; Humans; Hydroxyurea; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, T-Cell; Male; Neoplasm Invasiveness; Transplantation, Homologous | 2014 |
50-Year-Old Man With New-Onset Acute Kidney Injury.
Topics: Acute Kidney Injury; Antineoplastic Agents; Cisplatin; Cytarabine; Dexamethasone; Gout Suppressants; Humans; Lymphoma, T-Cell; Male; Middle Aged; Rehydration Solutions; Treatment Outcome; Tumor Lysis Syndrome; Urate Oxidase; Water-Electrolyte Imbalance | 2015 |
Cytomegalovirus Pneumonia after Anti-CC-chemokine Receptor 4 Monoclonal Antibody (Mogamulizumab) Therapy in an Angioimmunoblastic T-cell Lymphoma Patient.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cisplatin; Cyclophosphamide; Cytarabine; Cytomegalovirus Infections; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Humans; Immunoblastic Lymphadenopathy; Lymphoma, T-Cell; Male; Methylprednisolone; Middle Aged; Pneumonia, Viral; Prednisone; Receptors, CCR4; Vincristine | 2016 |
Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphoma.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Middle Aged; Neoplasms, Second Primary; Virus Latency | 2008 |
Ongoing remission after intensive ALL-type chemotherapy in pediatric intestinal T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Etoposide; Humans; Intestinal Neoplasms; Lymphoma, T-Cell; Male; Mercaptopurine; Methotrexate; Methylprednisolone; Neoplasm Staging; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Thioguanine; Vincristine | 2010 |
Hepatosplenic alphabeta T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Transplantation; Carboplatin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Liver Neoplasms; Lymphoma, T-Cell; Male; Methylprednisolone; Positron-Emission Tomography; Prednisolone; Receptors, Antigen, T-Cell, alpha-beta; Splenic Neoplasms; T-Lymphocytes; Tomography, X-Ray Computed; Transplantation Conditioning; Vincristine | 2010 |
Therapy-related leukemia cutis with histopathologic changes resembling xanthogranuloma.
Topics: Adult; Biopsy, Needle; Cytarabine; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Granuloma; Humans; Immunohistochemistry; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemic Infiltration; Lymphoma, T-Cell; Risk Assessment; Xanthomatosis | 2011 |
Cytosine arabinoside potentiates the apoptotic effect of bendamustine on several B- and T-cell leukemia/lymphoma cells and cell lines.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Bendamustine Hydrochloride; Cell Cycle; Cell Line, Tumor; Cytarabine; Humans; Leukemia; Leukemia, B-Cell; Leukemia, T-Cell; Lymphoma; Lymphoma, B-Cell; Lymphoma, T-Cell; Nitrogen Mustard Compounds | 2012 |
Primary cerebral angioimmunoblastic T-cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Confusion; Cytarabine; Diagnosis, Differential; Female; Gene Rearrangement; Genes, T-Cell Receptor gamma; Humans; Immunoblastic Lymphadenopathy; Immunohistochemistry; Lymphoma, T-Cell; Magnetic Resonance Imaging; Methotrexate; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Vision Disorders | 2013 |
High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kuwait; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Mercaptopurine; Mesna; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Survival Rate; Thioguanine; Treatment Outcome; Vincristine | 2003 |
Primary colorectal T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Barium Sulfate; Bleomycin; Colonoscopy; Colorectal Neoplasms; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Doxorubicin; Enema; Etoposide; Humans; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 2003 |
Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Humans; Killer Cells, Natural; Leukemia; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Remission Induction; Vincristine | 2003 |
Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Brain Neoplasms; Cause of Death; Combined Modality Therapy; Confidence Intervals; Cytarabine; Dose Fractionation, Radiation; Female; Follow-Up Studies; Humans; Injections, Intravenous; Injections, Spinal; Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Survival Analysis; Time Factors | 2003 |
Extranodal multiple involvement of enteropathy-type T-cell lymphoma without expression of CC chemokine receptor 7.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Movement; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Fatal Outcome; Humans; Immunophenotyping; Intestinal Mucosa; Intestinal Neoplasms; Intestine, Small; Lymph Nodes; Lymphoma, T-Cell; Male; Methylprednisolone; Neoplasm Invasiveness; Neoplastic Stem Cells; Organ Specificity; Pleural Effusion; Prednisone; Receptors, CCR7; Receptors, Chemokine; T-Lymphocyte Subsets; Vincristine; Viscera | 2004 |
[Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Eye Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, T-Cell; Middle Aged; Prognosis; Recurrence; Thiotepa | 2004 |
Hyperfractionated cyclophosphamide with high-doses of arabinosylcytosine and methotrexate (HyperCHiDAM Verona 897).
Topics: Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Prognosis; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2005 |
[High-dose chemotherapy with autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in complete response as consolidation therapy, second report].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Middle Aged; Prednisone; Remission Induction; Retrospective Studies; Transplantation, Autologous; Treatment Outcome; Vincristine | 2006 |
Antiblastic chemotherapy drugs up-modulate interferon-gamma receptor expression on human malignant T cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Division; Cisplatin; Cytarabine; Daunorubicin; Etoposide; Flow Cytometry; Interferon gamma Receptor; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, T-Cell; Neoplastic Stem Cells; Receptors, Interferon; T-Lymphocytes; Tumor Cells, Cultured; Up-Regulation | 1997 |
CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow Transplantation; CD3 Complex; CD56 Antigen; Cell Nucleus; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Female; Femoral Neoplasms; Herpesvirus 4, Human; Humans; Idarubicin; Immunophenotyping; Killer Cells, Natural; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methylprednisolone; Neoplasm Invasiveness; Neoplasm Proteins; Neoplastic Stem Cells; Pelvic Neoplasms; Prednisone; Quinine; Vincristine | 1997 |
[Combination chemotherapy with BH-AC, mitoxantrone, etoposide, and prednisolone to refractory or relapsed malignant lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Middle Aged; Mitoxantrone; Prednisolone | 1997 |
Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants.
Topics: Adolescent; Adult; Age Distribution; Age Factors; Antineoplastic Agents; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Immunophenotyping; Infant; Infant, Newborn; Lymphoma, B-Cell; Lymphoma, T-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone | 1998 |
Secondary acute myeloid leukemia following treatment with VP16-containing regimens for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Enzyme Inhibitors; Etoposide; Fatal Outcome; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leukemia, Monocytic, Acute; Leukemia, Myelomonocytic, Acute; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Methotrexate; Mitoxantrone; Neoplasm Proteins; Neoplasms, Second Primary; Prednisone; Topoisomerase II Inhibitors; Vincristine | 1998 |
Azidothymidine resistance of H9 human T-cell lymphoma cells is associated with decreased sensitivity to antitumor agents and inhibition of apoptosis.
Topics: Anti-HIV Agents; Antimetabolites; Antineoplastic Agents; Apoptosis; Cytarabine; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, T-Cell; Tumor Cells, Cultured; Zalcitabine; Zidovudine | 1998 |
Involvement of the appendix in a relapsed case of primary nasal NK/T-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Appendectomy; Appendiceal Neoplasms; Appendicitis; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Humans; Intestinal Perforation; Killer Cells, Natural; Leucovorin; Lymphoma, T-Cell; Male; Methotrexate; Methylprednisolone; Nitrosourea Compounds; Nose Neoplasms; Prednisone; Skin Neoplasms; Splenic Neoplasms; Tumor Virus Infections; Vincristine | 2000 |
Recurrent penicillin-resistant pneumococcal sepsis after matched unrelated donor (MUD) transplantation for refractory T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bone Marrow Transplantation; Carmustine; Cefotaxime; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Cytomegalovirus Infections; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Idarubicin; Immunocompromised Host; Immunosuppressive Agents; Levofloxacin; Lymphoma, T-Cell; Male; Melphalan; Ofloxacin; Penicillin Resistance; Pneumococcal Infections; Prednisone; Recurrence; Rifampin; Splenectomy; Streptococcus pneumoniae; Transplantation Conditioning; Vincristine | 2000 |
Nodal gamma/delta T cell lymphoma in complete remission following allogeneic bone marrow transplantation from an HLA-matched unrelated donor.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Bone Marrow; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Humans; Lymphoma, T-Cell; Male; Prednisolone; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Transplantation, Homologous; Vincristine | 2001 |
Primary central nervous system T-cell lymphoma.
Topics: Adult; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Cytarabine; Fatal Outcome; Humans; Lymphoma, T-Cell; Male; Methotrexate; Neoplasm Recurrence, Local; Prognosis | 2001 |
Guillain-Barré syndrome after allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Cyclophosphamide; Cytarabine; Fatal Outcome; Guillain-Barre Syndrome; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Leukemia, T-Cell; Lymphoma, T-Cell; Male; Parainfluenza Virus 1, Human; Respirovirus Infections; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2002 |
"Locked-in syndrome" after intrathecal cytosine arabinoside therapy for malignant immunoblastic lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Autopsy; Cisplatin; Cytarabine; Doxorubicin; Humans; Infusions, Intravenous; Injections, Spinal; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, T-Cell; Male | 1992 |